In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains
- PMID: 11036022
- PMCID: PMC101602
- DOI: 10.1128/AAC.44.11.3055-3060.2000
In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains
Abstract
Several studies have previously reported synergistic effects between vancomycin and a given beta-lactam or a given aminoglycoside against methicillin-resistant Staphylococcus aureus (MRSA) strains. The aim of our study was to exhaustively compare the effects of different combinations of a beta-lactam, vancomycin, and/or an aminoglycoside against 32 clinical MRSA strains with different aminoglycoside susceptibility patterns. The effects of 26 different beta-lactam-vancomycin and 8 different aminoglycoside-vancomycin combinations were first studied using a disk diffusion screening method. The best interactions with vancomycin were observed with either imipenem, cefazolin, or netilmicin. By checkerboard studies, imipenem-vancomycin and cefazolin-vancomycin each provided a synergistic bacteriostatic effect against 22 strains; the mean fractional inhibitory concentration (FIC) indexes were 0.35 and 0.46 for imipenem-vancomycin and cefazolin-vancomycin, respectively. The vancomycin-netilmicin combination provided an indifferent effect against all of the 32 strains tested; the mean of FIC index was 1. 096. The mean concentrations of imipenem, cefazolin, netilmicin, and vancomycin at which FIC indexes were calculated were clinically achievable. Killing experiments were then performed using imipenem, cefazolin, netilmicin, and vancomycin at one-half of the MIC, alone and in different combinations, against 10 strains. The vancomycin-netilmicin regimen was rarely bactericidal, even against strains susceptible to netilmicin. The imipenem-vancomycin and cefazolin-vancomycin combinations were strongly bactericidal against six and five strains, respectively. The addition of netilmicin markedly enhanced the killing activity of the combination of cefazolin or imipenem plus vancomycin, but only for the MRSA strains against which the beta-lactam-vancomycin combinations had no bactericidal effect. It is noteworthy that the latter strains were both susceptible to netilmicin and heterogeneously resistant to methicillin.
Similar articles
-
In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.Ann Clin Microbiol Antimicrob. 2006 Oct 12;5:25. doi: 10.1186/1476-0711-5-25. Ann Clin Microbiol Antimicrob. 2006. PMID: 17034644 Free PMC article.
-
β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.Antimicrob Agents Chemother. 2018 May 25;62(6):e00157-18. doi: 10.1128/AAC.00157-18. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29555635 Free PMC article.
-
[Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus].Jpn J Antibiot. 1993 Nov;46(11):939-45. Jpn J Antibiot. 1993. PMID: 8309069 Japanese.
-
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.Am J Med. 1986 Jun 30;80(6B):126-37. doi: 10.1016/0002-9343(86)90490-0. Am J Med. 1986. PMID: 3088998 Review.
-
Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome.Cell Mol Life Sci. 2005 Nov;62(22):2617-33. doi: 10.1007/s00018-005-5148-6. Cell Mol Life Sci. 2005. PMID: 16143832 Free PMC article. Review.
Cited by
-
Synergy of β-Lactams with Vancomycin against Methicillin-Resistant Staphylococcus aureus: Correlation of Disk Diffusion and Checkerboard Methods.J Clin Microbiol. 2016 Mar;54(3):565-8. doi: 10.1128/JCM.01779-15. Epub 2015 Dec 16. J Clin Microbiol. 2016. PMID: 26677253 Free PMC article.
-
Preparation, Physicochemical Characterization, Antimicrobial Effects, Biocompatibility and Cytotoxicity of Co-Loaded Meropenem and Vancomycin in Mesoporous Silica Nanoparticles.Biomedicines. 2023 Nov 16;11(11):3075. doi: 10.3390/biomedicines11113075. Biomedicines. 2023. PMID: 38002075 Free PMC article.
-
Synergistic Antimicrobial Metal Oxide-Doped Phosphate Glasses; a Potential Strategy to Reduce Antimicrobial Resistance and Host Cell Toxicity.ACS Biomater Sci Eng. 2022 Mar 14;8(3):1193-1199. doi: 10.1021/acsbiomaterials.1c00876. Epub 2022 Feb 24. ACS Biomater Sci Eng. 2022. PMID: 35199992 Free PMC article.
-
In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother. 2012 Jan;56(1):202-7. doi: 10.1128/AAC.05473-11. Epub 2011 Oct 17. Antimicrob Agents Chemother. 2012. PMID: 22006007 Free PMC article.
-
Interactions of antibiotics and methanolic crude extracts of Afzelia Africana (Smith.) against drug resistance bacterial isolates.Int J Mol Sci. 2011;12(7):4477-503. doi: 10.3390/ijms12074477. Epub 2011 Jul 13. Int J Mol Sci. 2011. PMID: 21845091 Free PMC article.
References
-
- Barr J G, Smyth E T M, Hogg G M. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis. 1990;9:804–809. - PubMed
-
- Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997. Morbid Mortal Weekly Rep. 1997;46:765–766. . (Erratum, 46:851, 1997.) - PubMed
-
- Centers for Disease Control and Prevention. Update: Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997. Morbid Mortal Weekly Rep. 1997;46:813–815. . (Erratum, 46:851, 1997.) - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources